MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas

…, S Tsukushi, Y Shido, H Sugiura… - American Journal of …, 2010 - Am Roentgen Ray Soc
OBJECTIVE. The objective of this study was to identify the MRI criteria that best differentiate
malignant peripheral nerve sheath tumors from benign neurofibromas. MATERIALS AND …

Predictors of survival in patients with bone metastasis of lung cancer

H Sugiura, K Yamada, T Sugiura, T Hida… - … and related research, 2008 - Springer
The prognosis of patients with bone metastasis from lung cancer has not been well documented.
We assessed the survival rates after bone metastasis and prognostic factors in 118 …

Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open …

A Kawai, N Araki, H Sugiura, T Ueda… - The Lancet …, 2015 - thelancet.com
Background Trabectedin binds to the minor groove of DNA and blocks DNA repair machinery.
Preclinical data have shown that trabectedin also modulates the transcription of the …

Clinical results of nonsurgical treatment for spinal metastases

…, J Inagaki, H Kobayashi, H Sugiura… - International Journal of …, 1998 - Elsevier
Purpose: In contrast with many analyses of surgical treatment for spinal metastases, there
have been only a few recent well-documented publications assessing nonsurgical treatment. …

The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: a Japanese Musculoskeletal Oncology Group (JMOG) study

…, A Kawai, N Araki, T Goto, T Yonemoto, H Sugiura… - Cancer, 2016 - Wiley Online Library
BACKGROUND Because the efficacy and safety of pazopanib in Japanese patients with
soft tissue sarcoma (STS) had not been evaluated previously in a large‐scale cohort, the …

Determining the site of the primary cancer in patients with skeletal metastasis of unknown origin: a retrospective study

H Katagiri, M Takahashi, J Inagaki, H Sugiura, S Ito… - Cancer, 1999 - Wiley Online Library
BACKGROUND When skeletal metastasis is the presenting problem and the primary site is
occult, there is a need to identify the primary site as soon as possible. However, the search …

SYT‐SSX breakpoint peptide vaccines in patients with synovial sarcoma: A study from the J apanese M usculoskeletal O ncology G roup

…, H Tsuchiya, T Osanai, T Sugita, H Sugiura… - Cancer …, 2012 - Wiley Online Library
In the present study, we evaluated the safety and effectiveness of SYT ‐ SSX ‐derived peptide
vaccines in patients with advanced synovial sarcoma. A 9‐mer peptide spanning the SYT …

[HTML][HTML] Relationship between the skeletal muscle mass index and physical activity of Japanese children: A cross-sectional, observational study

T Ito, H Sugiura, Y Ito, K Noritake, N Ochi - PLoS One, 2021 - journals.plos.org
Regular physical activity is an important component of physical health of children and has
been associated with increasing skeletal muscle mass and muscle strength. Children with low …

Clinical outcome of sacral chordoma with carbon ion radiotherapy compared with surgery

…, R Imai, S Tsukushi, Y Yamada, H Sugiura… - International Journal of …, 2011 - Elsevier
PURPOSE: To evaluate the efficacy, post-treatment function, toxicity, and complications of
carbon ion radiotherapy (RT) for sacral chordoma compared with surgery. METHODS AND …

[HTML][HTML] The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma

…, T Ueda, S Kakunaga, A Kawai, H Sugiura… - European Journal of …, 2020 - Elsevier
Purpose The role of chemotherapy (CT) and radiotherapy (RT) for management of extraskeletal
osteosarcoma (ESOS) remains controversial. We examined disease outcomes for ESOS …